International Journal of Clinical and Pharmaceutical Innovations

An International Peer Reviewed Open Access Journal

ISSN (Online): 3142-8665
CODEN (USA): IJCPSM

editor@ijcpi.com

International Journal of Clinical and Pharmaceutical Innovations

An International Peer Reviewed Open Access Journal

ISSN (Online): 3142-8665
CODEN (USA): IJCPSM

editor@ijcpi.com

INTEGRATIVE AYURVEDIC PROTOCOLS FOR TYPE 2 DIABETES MELLITUS: A CLINICAL EVIDENCE REVIEW AND METABOLIC SYNERGY FRAMEWORK

*Vd. Shubham Shukla, Dr. Muskan Patidar, Dr. Akanksha Alawa, Dr. Umesh Shukla, Dr. Salil Ku. Jain, Dr. Neha Mishra
Full Article DOI

Abstract

Background: Type 2 diabetes mellitus (T2DM) presents an escalating global metabolic challenge. Contemporary biomedical strategies heavily emphasize peripheral glycaemic containment rather than addressing foundational insulin resistance. Conversely, Ayurveda approaches this pathology as Prameha (Madhumeha), deploying a multi-pronged therapeutic matrix of Ahara (dietary optimization), Vihara (circadian lifestyle modification), Shodhan (Biological Purification), and targeted herbo-mineral pharmacology. Objective: This review evaluates recent clinical evidence (2017–2026) regarding the therapeutic efficacy, safety profiles, and systemic synergy of integrative Ayurvedic protocols co-managed with conventional biomedicine for T2DM. Materials and Methods: Peer-reviewed clinical trials, systematic reviews, meta-analyses, and national public health co-management initiatives published between 2017 and 2026 were aggregated via advanced academic indexing databases. The primary outcome metrics evaluated were Glycated Haemoglobin (HbA1c), Fasting Blood Glucose (FBG), Post-Prandial Blood Glucose (PPBG), and patient-reported Quality of Life (QoL). Results: A high-fidelity systematic review encompassing 199 randomized controlled trials (RCTs) and 21,191 participants demonstrated that Ayurvedic formulations achieve statistically significant independent HbA1c reductions (0.3%–1.6%). Integrative co-management configurations (Ayurveda combined with Metformin) consistently yielded an additional ~1% absolute reduction in HbA1c compared to conventional monotherapy, alongside optimized lipid clearance and enhanced insulin sensitivity indices. Monitored case series revealed substantial metabolic correction, facilitating safe pharmaceutical de-escalation or complete biomarker normalization (e.g., baseline HbA1c reducing from 11.2% to 5.7%). Adverse events were rare and limited to mild, transient gastrointestinal adjustments. Conclusion: Integrative Ayurvedic protocols offer an effective, safe, and systemically synergistic methodology for the clinical management of T2DM. To facilitate global public health policy translation, future research must enforce rigorous reporting standards and evaluate long-term microvascular and macrovascular outcomes via large-scale multi-centric RCTs.

References

  • Chattopadhyay K, Wang H, Kaur J, Nalbant G, Almaqhawi A, Kundakci B, et al. Effectiveness and Safety of Ayurvedic Medicines in Type 2 Diabetes Mellitus Management: A Systematic Review and Meta-Analysis. Front Pharmacol, 2022; 13: 821810.
  • Katti P, Katti S, U RB. Recent developments in Ayurvedic approach in the treatment of Type 1 and Type 2 Diabetes Mellitus: A comprehensive review. J Ayurveda Integr Med Sci., 2025; 9(10): 10-20.
  • Gordon AB, Buch Z, Baute V, Coeytaux R. Use of Ayurveda in the Treatment of Type 2 Diabetes Mellitus. Glob Adv Health Med., 2019; 8: 2164956119861094.
  • Sharma VK, Kaushik ML, Rani D. Role of Ayurveda in the Management of Diabetes Mellitus: A Comprehensive Review to explore the awareness. Res J Pharm Technol, 2023; 16(2): 894-898.
  • Patel S. Traditional Wisdom Meets Modern Science: Ayurveda For Diabetes Management. African J Biomed Res., 2024; 27(4s): 5545-5552.
  • Wasnik K, Shukla A, Mahto R. Possible management of type 2 diabetes mellitus through patient-centered Ayurvedic approach: An experience. J Ayurveda Case Rep., 2022; 5: 176-182.
  • Chavan S, Talmale M. Preventive Approach to Type II Diabetes Mellitus: A Case Study. Int J Adv Res Sci Commun Technol, 2024; 14(2): 2275-2279.
  • Kumari S, Patel A, Prasad B, M D, D LS, Solankure K, et al. Ayurveda Management of Diabetes Mellitus: A Comprehensive Evidence-Based Narrative Review. Int J Ayurvedic Med., 2025; 16(4): 6264-6272.
  • Sharma R, Shahi V, Khanduri S, Goyal A, Chaudhary SA, Rana R, et al. Effect of Ayurveda intervention, lifestyle modification and Yoga in prediabetic and type 2 diabetes under the National Programme (NPCDCS)–AYUSH integration project. Ayu., 2019; 40(1): 8-15.
  • Kumari S, Tubhaki B, Patil R, Sd L, M D. Efficacy of Integrated Ayurveda Treatment in Type 2 Diabetes mellitus with special reference to Prameha: A Randomised controlled Trial. Int J Ayurvedic Med., 2024; 15(1): 4334-4341.
  • Farseena K, Deshpande S, Scholar P. A Case Report on Ayurvedic Management of Type 2 Diabetes Mellitus. The Bioscan, 2025; 20(1): 83-87.

QR

QR Code

Citation

Vd. Shubham Shukla, Dr. Muskan Patidar, Dr. Akanksha Alawa, Dr. Umesh Shukla, Dr. Salil Ku. Jain, Dr. Neha Mishra. (2026). Integrative Ayurvedic Protocols For Type 2 Diabetes Mellitus: A Clinical Evidence Review And Metabolic Synergy Framework. International Journal of Clinical and Pharmaceutical Innovations, 1(6), 78-81.
DOI: https://doi.org/10.5281/zenodo.22211461

Keywords

Madhumeha, Integrative Medicine, Type 2 Diabetes Mellitus, HbA1c, Prameha Public Health.